Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 1.3T | 1.2T | 1.1T | 957.7B |
Cost of revenue | 254.7B | 228.3B | 230.4B | 193.6B |
Gross profit | 1.1T | 938.4B | 861.9B | 764.1B |
Operating expense | ||||
Research & development | 178.3B | 178.1B | 226.4B | 155.2B |
Selling general and admin | 536.5B | 527.9B | 621.0B | 459.6B |
Other operating expenses | — | — | — | — |
Operating income | 355.5B | 232.4B | 14.6B | 149.3B |
Non operating interest income | ||||
Income | 74.3B | 66.6B | 72.2B | 68.8B |
Expense | — | — | — | — |
Other income expense | 8.7B | -4.2B | 19.5B | -10.7B |
Pretax income | 438.5B | 294.8B | 106.3B | 207.4B |
Tax provision | 4.7B | 7.4B | 4.8B | 10.3B |
Net income | 433.7B | 287.4B | 101.6B | 197.1B |
Basic EPS | 0.1 | 0.1 | 0.0 | 0.1 |
Diluted EPS | 0.1 | 0.1 | 0.0 | 0.1 |
Basic average shares | 3.1T | 3.1T | 3.0T | 3.0T |
Diluted average shares | 3.4T | 3.4T | 3.3T | 3.2T |
EBITDA | 364.1B | 241.1B | 23.8B | 160.0B |
Net income from continuing op. | 433.7B | 287.4B | 101.6B | 197.1B |
Minority interests | -2.4B | -4.9B | 2.7B | -7.7B |
Preferred stock dividends | — | — | — | — |